- Home
- BNR vs AGFY Comparison
BNR vs AGFY Comparison
Compare BNR & AGFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- AGFY
- Stock Information
- Founded
- BNR 2014
- AGFY 2016
- Country
- BNR China
- AGFY United States
- Employees
- BNR N/A
- AGFY N/A
- Industry
- BNR Medical Specialities
- AGFY Military/Government/Technical
- Sector
- BNR Health Care
- AGFY Consumer Discretionary
- Exchange
- BNR Nasdaq
- AGFY Nasdaq
- Market Cap
- BNR 72.4M
- AGFY 73.0M
- IPO Year
- BNR 2020
- AGFY 2021
- Fundamental
- Price
- BNR $7.32
- AGFY $20.95
- Analyst Decision
- BNR
- AGFY
- Analyst Count
- BNR 0
- AGFY 0
- Target Price
- BNR N/A
- AGFY N/A
- AVG Volume (30 Days)
- BNR 5.5K
- AGFY 44.0K
- Earning Date
- BNR 12-03-2024
- AGFY 11-14-2024
- Dividend Yield
- BNR N/A
- AGFY N/A
- EPS Growth
- BNR N/A
- AGFY N/A
- EPS
- BNR N/A
- AGFY N/A
- Revenue
- BNR $72,832,704.00
- AGFY $10,385,000.00
- Revenue This Year
- BNR $52.90
- AGFY $468.67
- Revenue Next Year
- BNR $48.35
- AGFY N/A
- P/E Ratio
- BNR N/A
- AGFY N/A
- Revenue Growth
- BNR N/A
- AGFY N/A
- 52 Week Low
- BNR $2.62
- AGFY $2.71
- 52 Week High
- BNR $9.50
- AGFY $84.44
- Technical
- Relative Strength Index (RSI)
- BNR 63.72
- AGFY 37.71
- Support Level
- BNR $6.68
- AGFY $22.29
- Resistance Level
- BNR $7.32
- AGFY $27.99
- Average True Range (ATR)
- BNR 0.23
- AGFY 2.71
- MACD
- BNR -0.04
- AGFY -0.76
- Stochastic Oscillator
- BNR 93.63
- AGFY 3.32
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About AGFY Agrify Corporation
Agrify Corp is a leading provider of innovative cultivation and extraction solutions for the cannabis industry, bringing data, science, and technology to the forefront of the market. Its proprietary micro-environment-controlled Agrify Vertical Farming Units (VFUs) enable cultivators to produce high-quality products The products offered by the company include Integrated Grow Racks, LED Grow Lights, Hydroponics, and Vertical Farming Units.